Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Ebert S et al. | Candida esophagitis as the cause of swallowing disturbances in an 85-year-old patient with myasthenia gravis. | 2011 | Z Gerontol Geriatr | pmid:21732154 |
Brito GN et al. | In vitro antifungal susceptibility of Candida spp. oral isolates from HIV-positive patients and control individuals. | 2011 Jan-Feb | Braz Oral Res | pmid:21271179 |
Xu L et al. | Epirubicin enhances TRAIL-induced apoptosis in gastric cancer cells by promoting death receptor clustering in lipid rafts. | 2011 May-Jun | Mol Med Rep | pmid:21468584 |
Kaufman DA | "Getting to Zero": preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants. | 2012 | Early Hum. Dev. | pmid:22633513 |
Khan MA et al. | Immune stimulating and therapeutic potential of tuftsin-incorporated nystatin liposomes against Cryptococcus neoformans in leukopenic BALB/C mice. | 2012 | FEMS Immunol. Med. Microbiol. | pmid:22612788 |
Shanmughapriya S et al. | In vitro actinomycete biofilm development and inhibition by the polyene antibiotic, nystatin, on IUD copper surfaces. | 2012 | Biofouling | pmid:22963125 |
Blyth CC et al. | Chemoprophylaxis of neonatal fungal infections in very low birthweight infants: efficacy and safety of fluconazole and nystatin. | 2012 | J Paediatr Child Health | pmid:22970680 |
Silva MM et al. | Comparison of denture microwave disinfection and conventional antifungal therapy in the treatment of denture stomatitis: a randomized clinical study. | 2012 | Oral Surg Oral Med Oral Pathol Oral Radiol | pmid:22986242 |
Gerstein AC et al. | Parallel genetic changes and nonparallel gene-environment interactions characterize the evolution of drug resistance in yeast. | 2012 | Genetics | pmid:22714405 |
Kaomongkolgit R et al. | Antifungal activity of coronarin D against Candida albicans. | 2012 | Oral Surg Oral Med Oral Pathol Oral Radiol | pmid:22727093 |
Mima EG et al. | Comparison of Photodynamic Therapy versus conventional antifungal therapy for the treatment of denture stomatitis: a randomized clinical trial. | 2012 | Clin. Microbiol. Infect. | pmid:22731617 |
Fernández Campos F et al. | Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: ultrastructural effects and release studies. | 2012 | J Pharm Sci | pmid:22777575 |
Kalema N et al. | Oral antimicrobial rinse to reduce mycobacterial culture contamination among tuberculosis suspects in Uganda: a prospective study. | 2012 | PLoS ONE | pmid:22808020 |
Leibovitz E | Strategies for the prevention of neonatal candidiasis. | 2012 | Pediatr Neonatol | pmid:22503254 |
Al-Dwairi ZN et al. | The effect of antifungal agents on surface properties of poly(methyl methacrylate) and its relation to adherence of Candida albicans. | 2012 | J Prosthodont Res | pmid:22841909 |
Caliceti C et al. | Effect of plasma membrane cholesterol depletion on glucose transport regulation in leukemia cells. | 2012 | PLoS ONE | pmid:22859971 |
Kondo C et al. | Predictive genomic biomarkers for drug-induced nephrotoxicity in mice. | 2012 | J Toxicol Sci | pmid:22863853 |
Kovac M et al. | Miconazole and nystatin used as topical antifungal drugs interact equally strongly with warfarin. | 2012 | J Clin Pharm Ther | pmid:21332566 |
Shinde RB et al. | Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A. | 2012 | Ann. Clin. Microbiol. Antimicrob. | pmid:23035934 |
Hingston CD et al. | Impact of nystatin on Candida and the oral microbiome. | 2012 | Crit Care | pmid:22827886 |